I'm in no position to argue with your statement, but I believe that it is interferon that is the likely culprit;
http://press.endocrine.org/doi/full/10.1210/jc.2004-0627
"Interferon-a-Related Thyroid Disease"
I would be surprised if you had proof that it was ribavirin itself that caused the thyroid issues.
Ribavirin often causes anemia, but in 10 years of watching HCV boards yours is the first actual claim I have seen that RBV caused a heart attack. It is quite true that many people with advance age or HCV can have cardio/pulmonary issues. My informal observation is that a fair number of people w/ HCV smoke, which can also increase risk.
Heart attack is a fairly common occurrence in the USA;
http://www.cdc.gov/heartdisease/facts.htm
"About 600,000 people die of heart disease in the United States every year–that’s 1 in every 4 deaths.
Heart disease is the leading cause of death for both men and women. More than half of the deaths due to heart disease in 2009 were in men.
Coronary heart disease is the most common type of heart disease, killing nearly 380,000 people annually.
Every year about 720,000 Americans have a heart attack. Of these, 515,000 are a first heart attack and 205,000 happen in people who have already had a heart attack."
++++++++++++++++++++++++++
I'm just wondering if you have proof of either of your statements, or if they are opinion?
To me, they look like they *could* be extreme or incorrect statements. God forbid if they are being made to scare people *away* from a treatment (Abbvie) or *towards* a stock you happen to be invested in (GILD) : )
I think GILD is a great stock and has a great HCV program. You will notice that it uses RBV in some of it's upcoming G-3 treatments currently in trials. I do think that patients on RBV do require monitoring of hemoglobin levels. What were yours when you had the heart attack?
I was in the GILD ION -1 trials and did 21 weeks of RBV; 6 per day for 12 weeks (1200/mg/day). I had my RBV cut to 3/day (600mg) at 12 weeks thru 21 weeks.
I ran a 5K race 5 weeks after ending my TX at about a 8 minute/mile pace.
Not all people who take RBV have problems.
best, Willy
http://press.endocrine.org/doi/full/10.1210/jc.2004-0627
"Interferon-a-Related Thyroid Disease"
I would be surprised if you had proof that it was ribavirin itself that caused the thyroid issues.
Ribavirin often causes anemia, but in 10 years of watching HCV boards yours is the first actual claim I have seen that RBV caused a heart attack. It is quite true that many people with advance age or HCV can have cardio/pulmonary issues. My informal observation is that a fair number of people w/ HCV smoke, which can also increase risk.
Heart attack is a fairly common occurrence in the USA;
http://www.cdc.gov/heartdisease/facts.htm
"About 600,000 people die of heart disease in the United States every year–that’s 1 in every 4 deaths.
Heart disease is the leading cause of death for both men and women. More than half of the deaths due to heart disease in 2009 were in men.
Coronary heart disease is the most common type of heart disease, killing nearly 380,000 people annually.
Every year about 720,000 Americans have a heart attack. Of these, 515,000 are a first heart attack and 205,000 happen in people who have already had a heart attack."
++++++++++++++++++++++++++
I'm just wondering if you have proof of either of your statements, or if they are opinion?
To me, they look like they *could* be extreme or incorrect statements. God forbid if they are being made to scare people *away* from a treatment (Abbvie) or *towards* a stock you happen to be invested in (GILD) : )
I think GILD is a great stock and has a great HCV program. You will notice that it uses RBV in some of it's upcoming G-3 treatments currently in trials. I do think that patients on RBV do require monitoring of hemoglobin levels. What were yours when you had the heart attack?
I was in the GILD ION -1 trials and did 21 weeks of RBV; 6 per day for 12 weeks (1200/mg/day). I had my RBV cut to 3/day (600mg) at 12 weeks thru 21 weeks.
I ran a 5K race 5 weeks after ending my TX at about a 8 minute/mile pace.
Not all people who take RBV have problems.
best, Willy
Recent GILD News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/28/2026 12:55:23 AM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 05/28/2026 12:51:00 AM
- Phase 3 ASSURE Interim Data: Majority of People in the Study with ALP 1–1.67×ULN Achieved High and Sustained Composite ALP Normalization at 24 Months with Gilead’s Livdelzi (Seladelpar) • Business Wire • 05/27/2026 06:00:00 AM
- FDA Grants Accelerated Approval to Gilead’s Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV) • Business Wire • 05/22/2026 06:00:00 PM
- Gilead Receives CHMP Positive Opinion for Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer for Patients Not Candidates for PD-(L)1 Inhibitors • Business Wire • 05/22/2026 11:47:00 AM
- New ASCO and EHA 2026 Data Demonstrate Gilead and Kite’s Momentum Across Antibody-Drug Conjugates and Cell Therapy in Oncology • Business Wire • 05/21/2026 09:00:00 PM
- Gilead Sciences Completes Acquisition of Tubulis Further Strengthening Oncology Portfolio • Business Wire • 05/21/2026 01:30:00 PM
- Gilead Sciences and World Health Organization Expand Collaboration to Help Eliminate Visceral Leishmaniasis, a Fatal Parasitic Disease • Business Wire • 05/21/2026 07:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 08:15:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 09:50:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 09:45:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/18/2026 08:15:38 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/15/2026 08:09:08 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/15/2026 08:07:18 PM
- Gilead Prices $3 Billion of Senior Unsecured Notes • Business Wire • 05/15/2026 01:21:00 AM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 05/14/2026 09:11:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/14/2026 12:46:00 PM
- Gilead to Present New Data Advancing Care in PBC and Viral Hepatitis at EASL 2026 • Business Wire • 05/13/2026 12:30:00 PM
- Form 13F-HR - Quarterly report filed by institutional managers, Holdings • Edgar (US Regulatory) • 05/08/2026 09:00:48 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/07/2026 09:13:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 09:12:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:03:01 PM
- Gilead Sciences Announces First Quarter Financial Results • Business Wire • 05/07/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 08:40:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 08:36:45 PM
